The Department Of Pharmaceutical (Dop) Has Rejected The Review Application Filed By Ranbaxy Laboratories Ltd (Now Sun Pharmaceutical Industries Limited) Against The Notification S.O. No. 2095(E), Dated 20.08.2014 Issued By The Nppa Fixing The Ceiling Price Of Ciprofloxacin Hydrochloride Injection 200Mg/100Ml.The Applicant Ranbaxy Had Filed A Review Application, Dated 18.09.2014 Under Paragraph 31 Of Dpco, 2013 Against The Notification. But, The Review Application Was Disposed Of By The Dop In Its Review Order No. 31015/53/2015-Pi.I, Dated 14.05.2015.Dissatisfied Over The Dop
